NCT07080086

Brief Summary

Background The aim of this study is to explore the potential value of preoperative biological age as a predictor of intraoperative hemodynamic changes and postoperative renal function injury. Methods Collect data using medical record system and surgical anesthesia system, and gather patients who have undergone surgery. Calculate the preoperative biological age of the patient and analyze the correlation between preoperative biological age accelerated aging and intraoperative hemodynamics and postoperative renal function damage.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
268,833

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2015

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
9.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2024

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

July 15, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 23, 2025

Completed
Last Updated

July 23, 2025

Status Verified

September 1, 2023

Enrollment Period

9.3 years

First QC Date

July 15, 2025

Last Update Submit

July 15, 2025

Conditions

Keywords

Intraoperative Hypotensionpost-induction hypotensionAcute Kidney InjuryAcute kidney diseaseBiological ageBiological aging

Outcome Measures

Primary Outcomes (4)

  • The incidence ofn AKI

    Pateints encompasses an escalation in SCr of 50% or more, an increment of at least 0.3 mg/dL within 48 hours, or the need for RRT including haemodialysis, peritoneal dialysis, continuous renal replacement therapy, and kidney transplant. It was based on the 2012 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines.

    Within 7 days postoperative,

  • The incidence of AKD

    AKD was defined by a surge in SCr by more than 50%, or the initiation of RRT such as haemodialysis, peritoneal dialysis or continuous RRT.

    Within 8-90 days post-surgery

  • The incidence of IOH

    IOH was defined as the presence of intraoperative epoque with MAP below 60 mmHg.

    During intraoperative period

  • The incidence of PIH

    PIH was defined as at least one measurement of SAP below 90 mmHg.

    From induction of general anesthesia to 20 minutes post-induction.

Secondary Outcomes (3)

  • The incidence of AKI 2+

    0-7 days post-surgery

  • Cumulative duration of IOH and PIH

    During surgery

  • The cumulative AUC of IOH and PIH.

    During surgery

Study Arms (1)

Biological age

PhenoAge and Klemera-Doubal method biological age (KDM-BA), were utilized. PhenoAge was calculated using the combination of chronological age and nine clinical biomarkers (albumin, SCr, glucose, C-reactive protein (CRP), lymphocyte percentage, mean cell volume (MCV), red blood cell distribution width (RDW), alkaline phosphatase, and white blood cell count (WBC)). KDM-BA was calculated by chronological age and nine clinical biomarkers (albumin, SCr, CRP, alkaline phosphatase, systolic blood pressure, blood urea nitrogen, forced expiratory volume in one second (FEV1), glycated haemoglobin, and total cholesterol).

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing surgery with complete anaesthetic records

You may qualify if:

  • Surgical pateints

You may not qualify if:

  • (1) Lacking valid demographic information; (2) Lacking valid biological age; (3) Lacking blood pressure records

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Acute Kidney Injury

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Yali Ge, MD

    The First Affiliated Hospital with Nanjing Medical University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 15, 2025

First Posted

July 23, 2025

Study Start

January 1, 2015

Primary Completion

April 30, 2024

Study Completion

July 30, 2024

Last Updated

July 23, 2025

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share